Skip to Content
MilliporeSigma
  • HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells.

HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells.

Frontiers in pharmacology (2018-01-13)
Wen-Tsung Huang, Yu-Hsuan Tsai, Shang-Hung Chen, Ching-Wen Kuo, Yao-Lung Kuo, Kuo-Ting Lee, Wen-Chung Chen, Pei Chih Wu, Chun-Yu Chuang, Siao Muk Cheng, Chun-Hui Lin, Euphemia Yee Leung, Yung-Chieh Chang, Chun Hei Antonio Cheung
PMID29326587
ABSTRACT

Intrinsic or acquired resistance to hormone therapy is frequently reported in estrogen receptor positive (ER

MATERIALS
Product Number
Brand
Product Description
EHU002001
Sigma-Aldrich
MISSION® esiRNA, targeting human HDAC2
MAB2605
Sigma-Aldrich
Anti-ATG5 Antibody, clone 177.19, clone 177.19, from mouse
MAB1501
Sigma-Aldrich
Anti-Actin Antibody, clone C4, ascites fluid, clone C4, Chemicon®
07-645
Sigma-Aldrich
Anti-Sp1 Antibody, Upstate®, from rabbit
C2978
Sigma-Aldrich
CelLytic™ M, Cell Lysis Reagent, Suitable for Mammalian cell lysis and protein solubilization.
A2153
Sigma-Aldrich
Bovine Serum Albumin, lyophilized powder, ≥96% (agarose gel electrophoresis)